(Q45210813)

10 December 2017

Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses (English)

1 reference

10 December 2017

Gram-negative bacteria

0 references

author name string

J C Pechère

series ordinal

1

1 reference

10 December 2017

1 January 1988

1 reference

10 December 2017

1 reference

10 December 2017

35 Suppl 2

1 reference

10 December 2017

22-28

1 reference

Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

10 December 2017

1 reference

12 December 2020

Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosa.

1 reference

12 December 2020

Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

Combination therapy: a way to limit emergence of resistance?

1 reference

12 December 2020

Comparative activities of piperacillin, ceftazidime, and amikacin, alone and in all possible combinations, against experimental Pseudomonas aeruginosa infections in neutropenic rats

1 reference

12 December 2020

Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae

1 reference

12 December 2020

Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis

1 reference

12 December 2020

Development of beta-lactam-resistant Enterobacter cloacae in mice.

1 reference

12 December 2020

A plasmid-mediated cephalosporinase from Achromobacter species.

1 reference

12 December 2020

Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics

1 reference

12 December 2020

Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.

1 reference

12 December 2020

1 reference

12 December 2020

Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.

1 reference

12 December 2020

Hydrolytic model for cefotaxime and ceftriaxone resistance in beta-lactamase-derepressed Enterobacter cloacae

1 reference

12 December 2020

beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment

1 reference

12 December 2020

Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa

1 reference

12 December 2020

Properties of novel beta-lactamase produced by Bacteroides fragilis

1 reference

12 December 2020

In vitro antagonism of beta-lactam antibiotics by cefoxitin

1 reference

12 December 2020

Genetic analysis of drug resistance in Neisseria gonorrhoeae: production of increased resistance by the combination of two antibiotic resistance loci

1 reference

12 December 2020

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

1 reference

12 December 2020

Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance

1 reference

12 December 2020

Transferable resistance to 2nd and 3rd generation cephalosporins in a strain of Enterobacter cloacae

1 reference

12 December 2020

Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae

1 reference

12 December 2020

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

1 reference

12 December 2020

Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae

1 reference

12 December 2020

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism

1 reference

12 December 2020

Identifiers

PubMed ID

3260854

1 reference

PubMed ID

3260854